Astrocytic redox remodeling by amyloid beta peptide
Sanjay K Garg1, Victor Vitvitsky, Roger Albin
1Department of Biochemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Antioxidants & Redox Signaling
|January 18, 2011
Summary
Astrocytes
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Astrocytes are crucial for maintaining neuronal redox balance by supplying cysteine for glutathione synthesis.
- Amyloid beta (Aβ) peptides are implicated in Alzheimer's disease pathogenesis.
- Understanding astrocytic responses to Aβ is vital for neuroprotection strategies.
Purpose of the Study:
- To differentiate the astrocytic redox response to amyloid beta (Aβ) from a general oxidant.
- To investigate the impact of Aβ on key enzymes and redox potentials in astrocytes.
- To explore the link between astrocytic redox alterations and DNA synthesis.
Main Methods:
- Comparative analysis of astrocytic responses to acute and repeated Aβ exposure versus tertiary-butylhydroperoxide (t-BuOOH).
- Measurement of cystathionine β-synthase (CBS) and catalase protein levels.
- Assessment of transsulfuration flux, intracellular glutathione redox potential, and extracellular cystine uptake.
- Evaluation of DNA synthesis and analysis of cerebellar tissue from Alzheimer's disease patients.
Main Results:
- Aβ and t-BuOOH induced distinct astrocytic redox signatures.
- Acute Aβ increased cystathionine β-synthase (CBS) and transsulfuration flux; repeated Aβ decreased CBS and catalase.
- Aβ shifted intracellular glutathione redox potential oxidatively and extracellular cysteine/cystine redox potential reductively, unlike t-BuOOH.
- Aβ-induced redox changes, but not peroxide-induced ones, correlated with enhanced DNA synthesis.
- Lower CBS levels were observed in Alzheimer's disease patient cerebellum.
Conclusions:
- Astrocytic redox responses to Aβ are unique and differ from general oxidative stress.
- Alterations in astrocytic redox status, particularly involving CBS, may impair neuroprotection in Alzheimer's disease.
- Targeting astrocytic redox pathways presents a potential therapeutic avenue for Alzheimer's disease.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...